DEKA unveils PelviTouch therapy as non-invasive solution for erectile dysfunction at ESSM Congress

DEKA Laser, a subsidiary of El.En. S.p.A., has introduced PelviTouch therapy, a groundbreaking non-invasive treatment for erectile dysfunction therapy, at the European Society for Sexual Medicine (ESSM) congress. Known for its expertise in magnetic stimulation technology, DEKA has expanded its research in male intimate health to offer a solution that strengthens pelvic floor muscles, improving sexual function and addressing urinary incontinence treatment.

PelviTouch therapy was originally developed to assist both men and women in managing urinary incontinence treatment, but extensive research has led to its adaptation for erectile dysfunction therapy. By utilizing DEKA’s proprietary TOP Flat Magnetic Stimulation (TOP FMS) system, the technology stimulates pelvic floor muscles, generating contractions stronger than voluntary movements. This process enhances erectile function, reduces muscle spasms, and improves male intimate health without requiring pharmaceutical intervention.

What Are Experts Saying About PelviTouch Therapy?

At the ESSM congress, Paolo Salvadeo, CEO of DEKA and General Manager of El.En. S.p.A., highlighted the company’s commitment to advancing erectile dysfunction therapy through continuous investment in clinical research. He emphasized that DEKA has collaborated extensively with specialists in urology, andrology, and gynecology, focusing on improving treatment compliance and addressing concerns surrounding male intimate health.

Professor Nicola Mondaini, an Associate Professor of Urology, presented findings on PelviTouch therapy, detailing its effectiveness in treating erectile dysfunction therapy, urinary incontinence treatment, and Chronic Pelvic Pain Syndrome (CPPS). He stated that the therapy significantly alleviates pelvic pain, enhances urinary function, and improves overall quality of life by offering a non-invasive alternative to traditional treatments.

Dr. Giovanni Corona, an internationally recognized endocrinologist and andrologist who serves as President of ESSM, discussed the rising prevalence of erectile dysfunction therapy worldwide. He projected that by 2025, 322 million men globally will struggle with this condition, underscoring the need for innovative, effective, and non-invasive solutions such as PelviTouch. According to Dr. Corona, the therapy offers a breakthrough approach by normalizing pelvic floor muscles and optimizing erectile function.

How Does PelviTouch Therapy Improve Erectile Function?

PelviTouch therapy leverages magnetic stimulation technology to induce high-intensity contractions in the pelvic floor muscles. Unlike voluntary muscle exercises, this process bypasses the brain’s control, directly stimulating peripheral nerves to achieve deeper and stronger contractions. As a result, erectile function improves significantly due to increased pelvic muscle strength and enhanced blood circulation.

Beyond strengthening pelvic floor muscles, the therapy also relieves muscular stiffness and spasms, which are common issues associated with erectile dysfunction therapy and urinary incontinence treatment. By promoting muscle relaxation, PelviTouch ensures that patients experience greater comfort and improved sexual function.

Additionally, PelviTouch therapy has shown promising results in post-prostatectomy stress incontinence, helping men regain control over their urinary function after prostate surgery. Its ability to enhance the detrusor muscle also plays a role in reducing frequent urination urges, further supporting male intimate health.

Why Is PelviTouch Therapy Considered a Game-Changer in Erectile Dysfunction Treatment?

Unlike conventional erectile dysfunction therapy, which often relies on medications, injections, or invasive surgical procedures, PelviTouch offers a non-invasive alternative that eliminates concerns about side effects. With magnetic stimulation technology, it provides a safe and effective method for improving erectile function naturally.

DEKA’s research has demonstrated that the treatment can be seamlessly integrated into urological and andrological practices, offering a viable option for men who seek lasting improvements in male intimate health. Since PelviTouch therapy does not require direct skin contact or uncomfortable procedures, it ensures higher patient compliance and a more comfortable treatment experience.

What Does the Future Hold for Magnetic Stimulation in Male Intimate Health?

The introduction of PelviTouch therapy signals a major shift in the way erectile dysfunction therapy and urinary incontinence treatment are managed. As the demand for non-invasive treatments continues to grow, DEKA is positioning itself at the forefront of male intimate health innovation. With ongoing research and clinical trials, the potential applications of magnetic stimulation technology could extend beyond erectile dysfunction therapy, offering solutions for broader sexual health concerns.

Given the increasing prevalence of erectile dysfunction therapy globally, PelviTouch therapy has the potential to revolutionize the field by providing a safe, painless, and effective alternative. As more medical professionals adopt this technology, it could redefine the standard of care for male intimate health, giving millions of men a renewed sense of confidence and well-being.

The Rise of Non-Invasive Erectile Dysfunction Treatment

With PelviTouch therapy, DEKA has introduced a groundbreaking solution for men facing erectile dysfunction therapy and urinary incontinence treatment. By leveraging magnetic stimulation technology, the company has developed an approach that enhances erectile function, strengthens pelvic floor muscles, and improves male intimate health without the need for invasive interventions.

As research continues to validate its efficacy, PelviTouch therapy is poised to become a preferred choice among men seeking non-invasive erectile dysfunction therapy. By combining advanced medical technology with a patient-centered approach, DEKA is leading the charge in transforming male intimate health worldwide.